文章
醫療新知 > 被光激活的微小“納米機器”可以在數分鐘內殺死癌細胞

被光激活的微小“納米機器”可以在數分鐘內殺死癌細胞

04-09-2017

據外媒報道,科學家已經研發出被光激活的微小“納米機器”,可以在數分鐘內鑽入癌細胞並殺死它們。去年三位科學家因研發出“納米機器”而被授予諾貝爾化學獎。根據最新發表在《自然》雜志上的一項研究,英國達勒姆大學、美國萊斯大學以及北卡羅萊納州立大學的科學家們開發出了一些納米機器。當被光激活後,納米機器可以通過細胞壁進行鑽入癌細胞內部,並迅速殺死它們。

這些納米機器非常小,一個納米機器約相當於人類頭髮直徑的五萬分之一。每個納米機器對位於特定類型細胞上的蛋白質敏感,這有助於它們找到目標。一旦添加光線,它們每秒旋轉高達300萬次,這種旋轉提供了鑽入癌細胞所需的能量。沒有光,納米機器仍然可以找到分子,但只停留在表面上。
當科學家把這些納米機器放在充滿人類腎細胞的容器中時,納米機器在細胞中形成孔,並在數分鐘內殺死它們。當納米機器在癌前列腺細胞上釋放時,發生同樣的事情。研究人員希望在未來這些納米機器可以用來非常精確地遞送藥物,或者實際上殺死癌細胞,從而導致新形式的治療。

 

Molecular nanosubmarines can target and kill specific cancer cells

These tiny molecules can hunt down and kill specific cancer cells

These tiny molecules can hunt down and kill specific cancer cells (Credit: Rice University)

VIEW GALLERY – 4 IMAGES

In 2015, scientists from Rice University revealed they had created light-driven nanosubmarines. These tiny molecular machines were activated by ultraviolet light and based on earlier work from Nobel laureate Bernard Feringa, whose ground-breaking research won the prize for chemistry in 2016. These single-molecule machines have now been shown to be able to target, and drill into, specific cancer cells, paving the way for a variety of highly targeted future nanomedicine treatments.

These molecular machines consist of 244 atoms with a tail-like propeller that creates propulsion when exposed to UV light. After proving the concept worked back in 2015, the team moved on to exploring whether the molecular motor could penetrate an individual cell.

"We thought it might be possible to attach these nanomachines to the cell membrane and then turn them on to see what happened," explains chemist James Tour.

First the team needed to attach the molecular motor to a component that allowed it to target a specific cell. In these early experiments a peptide was utilized that drove the molecule to attach itself to the membrane of human prostate cancer cells. The molecules were shown to effectively locate and attach to the targeted cells, but not drill into them until specifically triggered by UV light. Once triggered, the motors spun up to two to three million rotations per second to break through the cell membrane and kill the cell within one to three minutes.

The obvious challenge that needs to be overcome is to develop an activation trigger other than ultraviolet light, which currently limits the molecular motors to being controllable when concentrated at the surface of tissue. Other triggers are currently being investigated, with near infra-red (IR) light looking like the best option to control these motors when delivered deep into a body.

"In this process, the motor will absorb two photons simultaneously and get enough energy to start the rotor," says Gufeng Wang, a chemist on the Rice University team. "Since near IR light has deep penetration depth, we are no longer limited to the surface of the tissue."

There is much work that still needs to be done before these molecular motors become a real, clinical treatment, but there are a variety of exciting outcomes this technology promises. As well as targeting and destroying cancer cells, the molecular motors could be utilized to deliver drugs directly into diseased cells.

As well as working on additional activation mechanisms, the team is embarking on a series of small animal tests to examine the effectiveness of the molecules on living organisms.

"The researchers are already proceeding with experiments in microorganisms and small fish to explore the efficacy in-vivo," says Tour. "The hope is to move this swiftly to rodents to test the efficacy of nanomachines for a wide range of medicinal therapies."

The research was published in the journal Nature and the video below provides a closer look at the team's breakthrough.

Source: Rice University

http://newatlas.com/molecular-motor-kills-cancer-cell/51173/

 

城中活動

2019-09-26 2:00 pm 美點廚房
2019-09-04 10:00 am 懷舊中秋燈籠工作坊

疑難排解

會員註冊


或許你會想看
醫管局推出HA GO實名登記制度
醫管局推出「HA Go」實名登記制度 電子化一站式管理病人健康資訊服務 醫管局於今年7月末推出一站式應用程式「HA Go」,以實名登記制度,利用電子化、多個獨立程式和新增貼心功能,提供約服務、健康護理、支付、醫療紀錄和用藥資訊等服務[...]
FDA准許瑞士製藥羅氏的Polivy治療彌漫性大B細胞淋巴瘤(R/R DLBCL)
FDA准許瑞士製藥羅氏的Polivy治療彌漫性大B細胞淋巴瘤(R/R DLBCL) 美國食品和藥物管理局(FDA)依據隨機對照臨床試驗中觀察到完全緩解率的結果,加速批准瑞士製藥羅氏(Roche)的化學免疫治療藥物 —— 抗體藥物結合[...]
一種新葯能破壞癌細胞生物鍾 / ScienceDailyCancer has a biological clock and this drug may keep it from ticking
一種新葯能破壞癌細胞生物鍾 北京新浪網 (2019-01-26 10:11) 新華社洛杉磯1月25日電(記者譚晶晶)美國南加州大學和日本名古屋大學的研究人員日前合作研發出一種新葯,可通過破壞癌細胞生物鍾的方式來抑制癌細胞生長。 眾所[...]
FDA 批准可以抑制 17 種腫瘤的新藥上市,治癒癌症的代價是一年要花上千萬台幣
FDA 批准可以抑制 17 種腫瘤的新藥上市,治癒癌症的代價是一年要花上千萬台幣   美國食品和藥物管理局(The Food and Drug Administration,簡稱 FDA)在星期一的時候批准一款抗癌新藥 V[...]
Google以深度學習協助檢測胸腺癌轉移,時間少一半、錯誤率降2倍
Google以深度學習協助檢測胸腺癌轉移,時間少一半、錯誤率降2倍   病理學家在LYNA的協助下,在主觀上認為工作變得更容易,並且每張幻燈片的檢驗時間從2分鐘縮短至1分鐘,而且判斷出錯率降低2倍。   Goog[...]
免疫細胞療法抗癌 專家:非人人有效
免疫細胞療法抗癌 專家:非人人有效   無藥可用的癌症患者未來可望用細胞治療,不用再跨海求援。萬芳醫院癌症中心主任賴基銘今天說,胰臟癌、肝癌、膀胱癌等癌友未來都有機會可用,但並非人人都有效。 過去在台灣要做細胞治療,得先依[...]
抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去 / Could matcha green tea be used to treat cancer? ‘Striking’ results show it kills cancer cells by stopping them from refuelling
抹茶可醫乳癌?英研究發現抹茶可令乳癌細胞休眠死去 19:21 2018/09/02   英國一項研究發現,抹茶萃取物可破壞乳癌細胞。   乳癌是香港女性頭號癌症,一旦不幸患上乳癌,可能需切除乳房作出治療。日本人喜[...]
中大醫學院師法耶魯開文物觀賞課
  中大的「文物觀賞課程」由中大醫學院助理院長(常務)趙偉仁(左)及中大文物館館長姚進莊(右)負責教授。圖中為中大醫學院院長陳家亮   (星島日報報道)吸取美國耶魯大學成功經驗,中文大學醫學院昨宣布與中大文物館合[...]
丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  / Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer
丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  (法新社資料圖片)   丹麥科學加宣布研發人工卵巢新技術,將來可望有助曾接受化療、放射治療等婦女重拾生育能力。 現有醫學技術主要有兩種方法,助有婦女保留生育能力。第一種是選擇冷藏[...]
患上乳癌後,妳要怎樣照顧自己的身體?
患上乳癌後,妳要怎樣照顧自己的身體?     治療乳癌可能是一個漫長的過程,但是在生活上和治療上都有一些方法可以助妳減少不適,讓妳能較安然和積極地渡過各個療程。     • [...]
《自然》重磅:肝癌大突破!拉斯克獎大牛發現全新抑癌蛋白,有望突破肝癌診療的瓶頸 | 科學大發現
《自然》重磅:肝癌大突破!拉斯克獎大牛發現全新抑癌蛋白,有望突破肝癌診療的瓶頸 | 科學大發現   在癌症這個殺手家族中,肝癌可以排得上全球老二了。在我國,肝癌也是高發癌種,而且由於其發病隱匿、疾病進展快,患者的預後極不樂[...]
轉移性乳癌的治療
轉移性乳癌的治療     轉移性乳癌指癌細胞已由乳房擴散至其他器官(第 4 期),一般不適合以手術切除,故治療方法多以藥物治療為主,可能包括化療、標靶藥物或荷爾蒙治療。視乎情況亦有可能配以放射治療。  [...]